Tranexamic Acid

Tranexamic acid transforms from hemostatic agent to top skin-brightening ingredient in 2025, with studies showing 30% greater efficacy than hydroquinone for melasma while causing 50% fewer side effects. La Roche-Posay, SkinMedica, and Paula's Choice capitalized on this by launching dedicated products, fueling a 220% demand increase. It now outperforms #5 azelaic acid for even-toned results, as measured by clinical melanin reduction trials this year.